NCT00844649 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 431
- group Id
- BG001
- value
- 430
- group Id
- BG002
- value
- 861
- units
- Participants
- groups
- description
- ABI-007 125 mg/m\^2 administered in combination with gemcitabine 1000 mg/m\^2 weekly for 3 weeks followed by one week of rest. Albumin-bound paclitaxel (ABI-007)/Gemcitabine : ABI-007 125 mg/m\^2 administered in combination with Gemcitabine 1000 mg/m\^2 weekly for 3 weeks, Days 1, 8, and 15 followed by one week of rest
- id
- BG000
- title
- Albumin-bound Paclitaxel (ABI-007)/Gemcitabine
- description
- Gemcitabine, 1000 mg/m\^2 administered weekly for 7 weeks followed by a week of rest (Cycle 1), followed by cycles of weekly administration for 3 weeks followed by a week of rest (Cycle 2 onward). Gemcitabine : Gemcitabine, 1000 mg/m2 administered weekly for 7 weeks, Day 1 through Day 43 followed by a week of rest (Cycle 1), followed by cycles of weekly administration for 3 weeks, Days 1, 8, and 15 followed by a week of rest (Cycle 2 onward).
- id
- BG001
- title
- Gemcitabine
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.70
- value
- 61.4
- group Id
- BG001
- spread
- 9.27
- value
- 63.0
- group Id
- BG002
- spread
- 10.04
- value
- 62.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 186
- group Id
- BG001
- value
- 173
- group Id
- BG002
- value
- 359
- title
- Female
- measurements
- group Id
- BG000
- value
- 245
- group Id
- BG001
- value
- 257
- group Id
- BG002
- value
- 502
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 17
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 32
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 378
- group Id
- BG001
- value
- 375
- group Id
- BG002
- value
- 753
- title
- White
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 51
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 138
- title
- 100% = normal, no complaints, no signs of disease
- categories
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 199
- group Id
- BG002
- value
- 378
- title
- 90% = normal activity, few symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 149
- group Id
- BG001
- value
- 128
- group Id
- BG002
- value
- 277
- title
- 80% = normal activity, some symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 63
- title
- 70% = caring for self, unable to work
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- 60% = needs help, can manage most tasks
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 50% = needs help often and medical care
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 40% = disabled; requires special care & assistance
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 30% = severely disabled; death is imminent
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 20% = hospitalized; requires supportive treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 10% = Moribund, fatal processes progressing fast
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 0% = Dead
- description
- The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is "perfect" health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed.
- param Type
- NUMBER
- title
- Karnofsky Performance Status (KPS)
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 191
- group Id
- BG001
- value
- 180
- group Id
- BG002
- value
- 371
- title
- Head
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 136
- group Id
- BG002
- value
- 268
- title
- Body
- categories
- measurements
- group Id
- BG000
- value
- 105
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 215
- title
- Tail
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Unknown = not specified
- description
- Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.
- param Type
- NUMBER
- title
- Pancreatic Primary Tumor Location
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 57
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 14
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 80
- title
- 4
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- 5
- categories
- measurements
- group Id
- BG000
- value
- 276
- group Id
- BG001
- value
- 262
- group Id
- BG002
- value
- 538
- title
- >5
- description
- Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.
- param Type
- NUMBER
- title
- Number of Baseline Lesions (Target + Non-Target)
- unit Of Measure
- participants
- population Description
- For the Karnofsky Performance Status (KPS) baseline characteristic, some of the participants did not have a baseline KPS recorded by the clinical site.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 431
- group Id
- BG001
- value
- 430
- group Id
- BG002
- value
- 861
- units
- Participants
- groups
- description
- ABI-007 125 mg/m\^2 administered in combination with gemcitabine 1000 mg/m\^2 weekly for 3 weeks followed by one week of rest. Albumin-bound paclitaxel (ABI-007)/Gemcitabine : ABI-007 125 mg/m\^2 administered in combination with Gemcitabine 1000 mg/m\^2 weekly for 3 weeks, Days 1, 8, and 15 followed by one week of rest
- id
- BG000
- title
- Albumin-bound Paclitaxel (ABI-007)/Gemcitabine
- description
- Gemcitabine, 1000 mg/m\^2 administered weekly for 7 weeks followed by a week of rest (Cycle 1), followed by cycles of weekly administration for 3 weeks followed by a week of rest (Cycle 2 onward). Gemcitabine : Gemcitabine, 1000 mg/m2 administered weekly for 7 weeks, Day 1 through Day 43 followed by a week of rest (Cycle 1), followed by cycles of weekly administration for 3 weeks, Days 1, 8, and 15 followed by a week of rest (Cycle 2 onward).
- id
- BG001
- title
- Gemcitabine
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.70
- value
- 61.4
- group Id
- BG001
- spread
- 9.27
- value
- 63.0
- group Id
- BG002
- spread
- 10.04
- value
- 62.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 186
- group Id
- BG001
- value
- 173
- group Id
- BG002
- value
- 359
- title
- Female
- measurements
- group Id
- BG000
- value
- 245
- group Id
- BG001
- value
- 257
- group Id
- BG002
- value
- 502
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 17
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 32
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 378
- group Id
- BG001
- value
- 375
- group Id
- BG002
- value
- 753
- title
- White
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 51
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 138
- title
- 100% = normal, no complaints, no signs of disease
- categories
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 199
- group Id
- BG002
- value
- 378
- title
- 90% = normal activity, few symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 149
- group Id
- BG001
- value
- 128
- group Id
- BG002
- value
- 277
- title
- 80% = normal activity, some symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 63
- title
- 70% = caring for self, unable to work
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- 60% = needs help, can manage most tasks
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 50% = needs help often and medical care
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 40% = disabled; requires special care & assistance
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 30% = severely disabled; death is imminent
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 20% = hospitalized; requires supportive treatment
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 10% = Moribund, fatal processes progressing fast
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- 0% = Dead
- description
- The Karnofsky Performance Status Scale (KPS) was designed to measure the level of participant activity and medical care requirements. A general measure of participant independence and has been widely used as a general assessment of participants with cancer. The Karnofsky score runs from 100 to 0, where 100 is "perfect" health and 0 is death. The primary purpose of its development was to allow physicians to evaluate a participant's ability to survive chemotherapy for cancer. Two participants from the Albumin bound paclitaxel arm and one from the Gemcitabine arm did not have KPS performed.
- param Type
- NUMBER
- title
- Karnofsky Performance Status (KPS)
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 191
- group Id
- BG001
- value
- 180
- group Id
- BG002
- value
- 371
- title
- Head
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 136
- group Id
- BG002
- value
- 268
- title
- Body
- categories
- measurements
- group Id
- BG000
- value
- 105
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 215
- title
- Tail
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Unknown = not specified
- description
- Main location or area of the pancreas where the disease is detected at diagnosis. Unknown location refers to disease area not being specified.
- param Type
- NUMBER
- title
- Pancreatic Primary Tumor Location
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 57
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 14
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 80
- title
- 4
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- 5
- categories
- measurements
- group Id
- BG000
- value
- 276
- group Id
- BG001
- value
- 262
- group Id
- BG002
- value
- 538
- title
- >5
- description
- Target lesions are those measurable at baseline and are generally the largest lesions, most reliably measured and most representative of the participants sites of disease. Non target lesions are all of the sites of disease present at baseline not classified as target lesions. They include bone and cystic lesions and pleural/pericardial effusion/ascites. The Independent Radiology Reviewers (IRR) only evaluated scans for those with baseline and follow-up scans.
- param Type
- NUMBER
- title
- Number of Baseline Lesions (Target + Non-Target)
- unit Of Measure
- participants
- population Description
- For the Karnofsky Performance Status (KPS) baseline characteristic, some of the participants did not have a baseline KPS recorded by the clinical site.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle